Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -244.91% is 544% below its 5-year average of -38.04%, around the middle of its 5-year range (-424.82%–32.44%).
As of the fiscal period ended Tuesday, June 30, 2026. 262.26% below its 12-month average of -67.61%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -244.91%.
RETURN ON EQUITY (ROE)
-244.91%
RETURN ON EQUITY (ROE) AVG TTM
-67.61%
RETURN ON EQUITY (ROE) AVG 3Y
-37.46%
RETURN ON EQUITY (ROE) AVG 5Y
-38.04%
RETURN ON EQUITY (ROE) AVG 10Y
-107.30%
RETURN ON EQUITY (ROE) AVG 15Y
-82.28%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-262.26%
CURRENT VS 3Y AVG
-553.83%
CURRENT VS 5Y AVG
-543.87%
CURRENT VS 10Y AVG
-128.25%
CURRENT VS 15Y AVG
-197.63%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 651 covered companies
CURRENT VS SECTOR MEDIAN
-509.22%
vs the sector median at left
Harrow Health, Inc.
Market Cap
$1.13B
Return on Equity (ROE)
-244.91%
TTM Avg
-67.61%
3Y Avg
-37.46%
5Y Avg
-38.04%
Market Cap
$1.13B
Return on Equity (ROE)
10.23%
TTM Avg
17.11%
3Y Avg
18.25%
5Y Avg
14.55%
Market Cap
$1.13B
Return on Equity (ROE)
-6.16%
TTM Avg
-10.85%
3Y Avg
-14.08%
5Y Avg
-9.38%
Market Cap
$1.14B
Return on Equity (ROE)
N/A
TTM Avg
35.70%
3Y Avg
35.70%
5Y Avg
35.70%
Market Cap
$1.15B
Return on Equity (ROE)
2.51%
TTM Avg
3.60%
3Y Avg
0.50%
5Y Avg
-7.05%
Market Cap
$1.15B
Return on Equity (ROE)
-17.40%
TTM Avg
-189.25%
3Y Avg
-172.42%
5Y Avg
-134.67%
Market Cap
$1.10B
Return on Equity (ROE)
-281.14%
TTM Avg
-124.20%
3Y Avg
-84.35%
5Y Avg
-63.72%
Market Cap
$1.09B
Return on Equity (ROE)
-39.54%
TTM Avg
-24.09%
3Y Avg
36.77%
5Y Avg
36.77%
Market Cap
$1.09B
Return on Equity (ROE)
22.66%
TTM Avg
22.95%
3Y Avg
21.85%
5Y Avg
17.09%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.13B | -244.91% | -67.61% | -37.46% | -38.04% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 10.23% | 17.11% | 18.25% | 14.55% |
| OPKO Health, Inc. (OPK)vs › | $1.13B | -6.16% | -10.85% | -14.08% | -9.38% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | N/A | 35.70% | 35.70% | 35.70% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 2.51% | 3.60% | 0.50% | -7.05% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -17.40% | -189.25% | -172.42% | -134.67% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | -281.14% | -124.20% | -84.35% | -63.72% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -39.54% | -24.09% | 36.77% | 36.77% |
| IRadimed Corporation (IRMD)vs › | $1.09B | 22.66% | 22.95% | 21.85% | 17.09% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.18B | -50.93% | -117.72% | -113.46% | -86.51% |
ROE
-244.9%
ROA
-8.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -244.91% |
| 2026-03-31 | -52.12% |
| 2025-12-31 | -9.80% |
| 2025-09-30 | -10.61% |
| 2025-06-30 | -20.60% |
| 2025-03-31 | -38.43% |
| 2024-12-31 | -25.10% |
| 2024-09-30 | -57.62% |
| 2024-06-30 | -57.37% |
| 2024-03-31 | -51.74% |
| 2023-12-31 | -34.70% |
| 2023-09-30 | -18.75% |
| 2023-06-30 | -72.66% |
| 2023-03-31 | -83.59% |
| 2022-12-31 | -51.05% |
| 2022-06-30 | -424.82% |
| 2022-03-31 | -204.76% |
| 2021-12-31 | -159.55% |
| 2021-09-30 | -56.91% |
| 2021-06-30 | 32.44% |
| 2021-03-31 | 34.60% |
| 2020-12-31 | -12.35% |
| 2020-09-30 | -7.32% |
| 2020-06-30 | -139.60% |
| 2020-03-31 | -157.12% |
| 2019-12-31 | 0.61% |
| 2019-09-30 | 65.29% |
| 2019-06-30 | 70.14% |
| 2019-03-31 | 79.59% |
| 2018-12-31 | 59.09% |
| 2018-09-30 | -140.94% |
| 2018-06-30 | -253.32% |
| 2017-12-31 | -458.32% |
| 2017-09-30 | -408.86% |
| 2017-06-30 | -176.22% |
| 2017-03-31 | -368.57% |
| 2016-12-31 | -296.75% |
| 2016-09-30 | -639.44% |
| 2016-06-30 | -324.73% |
| 2016-03-31 | -196.97% |
| 2015-09-30 | -602.50% |
| 2015-06-30 | -229.39% |
| 2015-03-31 | -175.41% |
| 2014-12-31 | -124.15% |
| 2014-09-30 | -90.00% |
| 2014-06-30 | -73.73% |
| 2014-03-31 | -61.63% |
| 2013-12-31 | -50.58% |
| 2013-09-30 | -44.13% |
| 2013-06-30 | -36.96% |
| 2013-03-31 | -29.73% |
| 2012-12-31 | -53.86% |
| 2012-09-30 | -38.94% |
| 2012-06-30 | -41.09% |
| 2009-12-31 | -788.83% |
| 2009-09-30 | -386.44% |
| 2009-06-30 | -237.17% |
| 2009-03-31 | -149.60% |
| 2008-12-31 | -72.27% |
| 2008-09-30 | -71.93% |
| 2008-06-30 | -88.87% |
